Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

14.70
+0.97007.07%
Volume:203.97K
Turnover:2.99M
Market Cap:37.44M
PE:- -
High:14.80
Open:14.34
Low:14.34
Close:13.73
52wk High:36.00
52wk Low:9.23
Shares:2.55M
Float Shares:2.55M
Volume Ratio:3.51
T/O Rate:8.00%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk Stock (NVO) Recovers as Earnings Surprise to the Upside

TIPRANKS
·
Aug 05

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Novo Nordisk Wins Dutch Injunction in Ceban Semaglutide Patent Case

MT Newswires Live
·
Aug 05

Novo Nordisk CEO Remains Open to Bolt-on Acquisitions, but Rules Out Transformative Deals

Dow Jones
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

UBS Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Aug 05

Novo-Nordisk CEO Defends Wegovy Oral Pill Amid Pricing Pressure, Shares Slide on Sales Concern

Deep News
·
Aug 05

European Stocks Extend Record Highs

Dow Jones
·
Aug 05

Novo Nordisk Shares Likely to Fall at Open, but Less than in U.S. Session

Dow Jones
·
Aug 05

Novo Nordisk A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Novo Nordisk Earnings Beat but Study Data, Wegovy Pill Sales Underwhelm

Dow Jones
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Novo Nordisk Q2 Adj. EPS $0.96 Beats $0.81 Estimate, Sales $12.209B Beat $11.350B Estimate

Benzinga Earnings
·
Aug 05

NYSE Most Active Issues

Dow Jones
·
Aug 05

The Wegovy Pill's 'surprise Miss' is One Reason Novo Nordisk's Stock is Down

Dow Jones
·
Aug 05

Wegovy Maker Novo Nordisk Lifts Annual Forecast Amid Rising Demand for Weight-Loss Drugs

Deep News
·
Aug 05

Novo Nordisk Raises Earnings Guidance. the Stock Sinks.

Dow Jones
·
Aug 05

Wegovy-Maker Novo Nordisk Raises Full-Year Guidance as Appetite for Weight-Loss Drugs Grows

Dow Jones
·
Aug 05

Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results

TIPRANKS
·
Aug 05

Novo Nordisk Q2 Lifts FY Guidance on Stronger GLP-1 Demand

Reuters
·
Aug 05